HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Primary reconstruction of the common truncus arteriosus in infants, using modified pulmonary homograft].

Abstract
Truncus arteriosus communis (TAC) is a complex heart disease, it presents 1% of the congenital heart defects. A 7 weeks old infant with cardiac failure was operated on with TAC. The bicuspidized (14 mm diameter) pulmonary homograft valved conduit was used to reconstruct the right ventricular outflow tract (RVOT). The sternum closure was delayed. The important points of the indications for the surgical management of TAC: 1. Management or prevention of the pulmonary hypertensive crisis. 2. Patient's age. 3. Reconstruction of the RVOT (choices: homograft, dacron valve conduit, autologous pericardial valve conduit, porcine aortic root, direct anastomosis of the pulmonary trunc to the right ventricle). The surgical management is based on the optimal combination of these three important points. This is the first successfully performed primary surgical repair of an infant with TAC using modified pulmonary homograft in Hungary.
AuthorsI Hartyánszky, K Kádár, Z Prodán, A Székely, C Tamás
JournalOrvosi hetilap (Orv Hetil) Vol. 140 Issue 24 Pg. 1361-3 (Jun 13 1999) ISSN: 0030-6002 [Print] Hungary
Vernacular TitleTruncus arteriosus communis primer rekonstrukciója csecsemökorban, méretre alakított pulmonalis homograft felhasználásával.
PMID10439638 (Publication Type: Case Reports, Journal Article)
Topics
  • Echocardiography
  • Heart Septal Defects, Atrial (diagnostic imaging, surgery)
  • Humans
  • Infant, Newborn
  • Lung (surgery)
  • Male
  • Transplantation, Homologous
  • Truncus Arteriosus, Persistent (diagnostic imaging, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: